Latest TCG Crossover Management, LLC Stock Portfolio
$1.26Billion
Equity Portfolio Value
Last Reported on: 15 May, 2024
About TCG Crossover Management, LLC and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, TCG Crossover Management, LLC reported an equity portfolio of $1.3 Billions as of 31 Mar, 2024.
The top stock holdings of TCG Crossover Management, LLC are , DYN, ATXS. The fund has invested 12.4% of it's portfolio in CG ONCOLOGY, INC. and 6% of portfolio in DYNE THERAPEUTICS, INC.
The fund managers got completely rid off ICOSAVAX INC (ICVX), RAYZEBIO, INC. and GRACELL BIOTECHNOLOGIES INC. (GRCL) stocks. They significantly reduced their stock positions in CABALETTA BIO, INC (CABA), KALVISTA PHARMACEUTICALS, INC (KALV) and AN2 THERAPEUTICS, INC. (ANTX). TCG Crossover Management, LLC opened new stock positions in CG ONCOLOGY, INC., ASTRIA THERAPEUTICS, INC. (ATXS) and KEROS THERAPEUTICS, INC. (KROS). The fund showed a lot of confidence in some stocks as they added substantially to KODIAK SCIENCES INC (KOD), DYNE THERAPEUTICS, INC (DYN) and SILENCE THERAPEUTICS PLC (SLN).
The top stock holdings of TCG Crossover Management, LLC are , DYN, ATXS. The fund has invested 12.4% of it's portfolio in CG ONCOLOGY, INC. and 6% of portfolio in DYNE THERAPEUTICS, INC.
The fund managers got completely rid off ICOSAVAX INC (ICVX), RAYZEBIO, INC. and GRACELL BIOTECHNOLOGIES INC. (GRCL) stocks. They significantly reduced their stock positions in CABALETTA BIO, INC (CABA), KALVISTA PHARMACEUTICALS, INC (KALV) and AN2 THERAPEUTICS, INC. (ANTX). TCG Crossover Management, LLC opened new stock positions in CG ONCOLOGY, INC., ASTRIA THERAPEUTICS, INC. (ATXS) and KEROS THERAPEUTICS, INC. (KROS). The fund showed a lot of confidence in some stocks as they added substantially to KODIAK SCIENCES INC (KOD), DYNE THERAPEUTICS, INC (DYN) and SILENCE THERAPEUTICS PLC (SLN).
New Buys
| Ticker | $ Bought |
|---|---|
| CG ONCOLOGY, INC. | 156,732,000 |
| ASTRIA THERAPEUTICS, INC. | 74,300,900 |
| KEROS THERAPEUTICS, INC. | 58,212,600 |
| OCULAR THERAPEUTIX, INC. | 48,404,200 |
| EDGEWISE THERAPEUTICS, INC. | 41,454,600 |
| MINERALYS THERAPEUTICS, INC. | 41,120,700 |
| ADVERUM BIOTECHNOLOGIES, INC. | 28,397,900 |
| SOLENO THERAPEUTIVS, INC. | 23,540,000 |
New stocks bought by TCG Crossover Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| KODIAK SCIENCES INC | 235 |
| DYNE THERAPEUTICS, INC | 60.6 |
| SILENCE THERAPEUTICS PLC | 56.56 |
| TOURMALINE BIO INC | 46.6 |
| COGENT BIOSCIENCES INC | 10.36 |
Additions to existing portfolio by TCG Crossover Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| CABALETTA BIO, INC | -82.17 |
| KALVISTA PHARMACEUTICALS, INC | -65.74 |
| AN2 THERAPEUTICS, INC. | -41.93 |
| TARSUS PHARMACEUTICALS, INC. | -30.54 |
| GERON CORP | -25.6 |
| STRUCTURE THERAPEUTICS INC | -24.23 |
| MADRIGAL PHARMACEUTICALS INC | -17.03 |
TCG Crossover Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| GRACELL BIOTECHNOLOGIES INC. | -45,328,500 |
| ICOSAVAX INC | -58,370,400 |
| TAYSHA GENE THERAPIES, INC. | -5,155,760 |
| RAYZEBIO, INC. | -54,082,200 |
| NURIX THERAPEUTICS INC | -7,406,190 |
TCG Crossover Management, LLC got rid off the above stocks
Current Stock Holdings of TCG Crossover Management, LLC
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ADVM | ADVERUM BIOTECHNOLOGIES, INC. | 2.24 | 2,008,340 | 28,397,900 | NEW | ||
| ANTX | AN2 THERAPEUTICS, INC. | 0.40 | 1,555,120 | 5,054,130 | REDUCED | -41.93 | |
| ATXS | ASTRIA THERAPEUTICS, INC. | 5.87 | 5,278,930 | 74,300,900 | NEW | ||
| AVTE | AEROVATE THERAPEUTICS INC | 5.15 | 2,201,270 | 65,091,700 | UNCHANGED | 0.00 | |
| CABA | CABALETTA BIO, INC | 0.12 | 86,795 | 1,480,720 | REDUCED | -82.17 | |
| CCCC | C4 THERAPEUTICS, INC. | 0.82 | 1,276,570 | 10,429,600 | UNCHANGED | 0.00 | |
| CMPS | COMPASS PATHWAYS PLC | 2.54 | 3,858,000 | 32,098,600 | UNCHANGED | 0.00 | |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1.82 | 2,040,820 | 23,061,200 | UNCHANGED | 0.00 | |
| COGT | COGENT BIOSCIENCES INC | 3.30 | 6,214,380 | 41,760,600 | ADDED | 10.36 | |
| DYN | DYNE THERAPEUTICS, INC | 5.95 | 2,650,150 | 75,237,800 | ADDED | 60.6 | |
| EWTX | EDGEWISE THERAPEUTICS, INC. | 3.28 | 2,272,730 | 41,454,600 | NEW | ||
| GERN | GERON CORP | 4.54 | 17,391,600 | 57,392,400 | REDUCED | -25.6 | |
| GRCL | GRACELL BIOTECHNOLOGIES INC. | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ICVX | ICOSAVAX INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| INBX | INHIBRX,INC | 4.84 | 1,750,390 | 61,193,500 | UNCHANGED | 0.00 | |
| KALV | KALVISTA PHARMACEUTICALS, INC | 1.09 | 1,163,360 | 13,797,400 | REDUCED | -65.74 | |
| KOD | KODIAK SCIENCES INC | 0.37 | 899,999 | 4,734,000 | ADDED | 235 | |
| KROS | KEROS THERAPEUTICS, INC. | 4.60 | 879,344 | 58,212,600 | NEW | ||
| KURA | KURA ONCOLOGY INC | 2.40 | 1,423,640 | 30,366,300 | UNCHANGED | 0.00 | |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 3.15 | 149,283 | 39,864,500 | REDUCED | -17.03 | |
| NKTR | NEKTAR THERAPEUTICS | 0.30 | 4,000,000 | 3,736,800 | NEW | ||
| NRIX | NURIX THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| OCUL | OCULAR THERAPEUTIX, INC. | 3.83 | 5,319,150 | 48,404,200 | NEW | ||
| SLN | SILENCE THERAPEUTICS PLC | 5.63 | 3,295,350 | 71,179,600 | ADDED | 56.56 | |
| SLNO | SOLENO THERAPEUTIVS, INC. | 1.86 | 550,000 | 23,540,000 | NEW | ||
| SVRA | SAVARA INC. | 3.94 | 10,000,000 | 49,800,000 | UNCHANGED | 0.00 | |
| TARS | TARSUS PHARMACEUTICALS, INC. | 2.28 | 793,829 | 28,855,700 | REDUCED | -30.54 | |
| TRDA | ENTRADA THERAPEUTICS INC | 0.66 | 584,955 | 8,288,810 | UNCHANGED | 0.00 | |
| TSHA | TAYSHA GENE THERAPIES, INC. | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| TYRA | TYRA BIOSCIENCES INC | 2.58 | 1,989,100 | 32,621,300 | UNCHANGED | 0.00 | |
| VSTA | VISTAGEN THERAPEUTICS INC | 1.12 | 2,676,580 | 14,132,300 | UNCHANGED | 0.00 | |
| VTYX | VENTYX BIOSCIENCES, INC | 0.36 | 815,724 | 4,486,480 | UNCHANGED | 0.00 | |
| CG ONCOLOGY, INC. | 12.39 | 3,570,210 | 156,732,000 | NEW | |||
| STRUCTURE THERAPEUTICS INC | 5.42 | 1,598,420 | 68,508,300 | REDUCED | -24.23 | ||
| MINERALYS THERAPEUTICS, INC. | 3.25 | 3,185,180 | 41,120,700 | NEW | |||
| TOURMALINE BIO INC | 2.67 | 1,477,590 | 33,836,900 | ADDED | 46.6 | ||
| ABIVAX SA | 1.24 | 1,100,000 | 15,730,000 | UNCHANGED | 0.00 | ||
| RAYZEBIO, INC. | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 |